BAM
Blueshift Asset Management’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-8,599
| Closed | -$331K | – | 407 |
|
|
2024
Q2 | $331K | Buy |
+8,599
| New | +$331K | 0.11% | 227 |
|
|
2023
Q3 | – | Sell |
-5,719
| Closed | -$204K | – | 339 |
|
|
2023
Q2 | $204K | Buy |
+5,719
| New | +$204K | 0.08% | 303 |
|
|
2022
Q4 | – | Sell |
-23,640
| Closed | -$696K | – | 461 |
|
|
2022
Q3 | $696K | Buy |
+23,640
| New | +$696K | 0.15% | 197 |
|
|
2022
Q2 | – | Sell |
-4,989
| Closed | -$217K | – | 805 |
|
|
2022
Q1 | $217K | Buy |
+4,989
| New | +$217K | 0.02% | 714 |
|
|
2021
Q2 | – | Sell |
-26,412
| Closed | -$943K | – | 1010 |
|
|
2021
Q1 | $943K | Buy |
26,412
+4,467
| +20% | +$159K | 0.1% | 289 |
|
|
2020
Q4 | $808K | Buy |
21,945
+10,763
| +96% | +$396K | 0.1% | 310 |
|
|
2020
Q3 | $421K | Buy |
+11,182
| New | +$421K | 0.06% | 381 |
|
|
2019
Q4 | – | Sell |
-19,996
| Closed | -$853K | – | 881 |
|
|
2019
Q3 | $853K | Buy |
19,996
+3,171
| +19% | +$135K | 0.13% | 225 |
|
|
2019
Q2 | $673K | Buy |
16,825
+3,371
| +25% | +$135K | 0.09% | 334 |
|
|
2019
Q1 | $562K | Sell |
13,454
-707
| -5% | -$29.5K | 0.08% | 368 |
|
|
2018
Q4 | $541K | Buy |
+14,161
| New | +$541K | 0.1% | 329 |
|